DocMorris Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/30/2026)
| Balance Sheet | Total Assets | 825,404,000.00 | ROE | 49.56 % |
| Balance Sheet | Total Equity | 409,100,000.00 | ROA | -16.28 % |
| Cashflow | Capital Expenditures | -1,772,000.00 | P/FCF | -8.07 |
| Cashflow | Free Cash Flow | -90,031,000.00 | – | – |
| Cashflow | Operating Cash Flow | -88,259,000.00 | P/CF | -8.23 |
| Income | Earnings per Share (diluted) | -2.60 | Div. Yield | – |
| Income | Net Income | -134,400,000.00 | P/E | -5.42 |
| Income | Shares Outstanding | 51,619,000.00 | P/B | 1.78 |
| Income | Total Revenue | 1,124,500,000.00 | P/S | 0.65 |
Ratios calculated on: 10/14/2026
Company Description
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.zurrosegroup.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more